Organ size increases with obesity and correlates with cancer risk

Haley Grant Yifan Zhang, Lu Li, Yan Wang, Satomi Kawamoto, Sophie Pénisson, Daniel Fadaei Fouladi, Shahab Shayesteh, Alejandra Blanco, Saeed Ghandili, Eva S. Zinreich, Jefferson S. Graves, Seyoun Park, Scott E. Kern, Jody E. Hooper, Alan Yuille, Elliot K. Fishman, Linda C. Chu, Cristian TomasettiarXiv 2020 · DOI · arXiv

TL;DR

While the link between obesity and cancer has been recognized for decades, the underlying mechanism has remained a mystery. This paper proposes a surprisingly simple explanation: obesity causes internal organs to grow significantly larger, increasing the total number of cells at risk of becoming cancerous. By analyzing CT scans and literature data, the researchers show that organ volume scales with BMI and that this increase in "cellular targets" explains nearly 80% of the associated cancer risk.

What Problem Does This Paper Address?

Epidemiological data is clear: obesity is a major driver of cancer. However, the why has proven elusive. Traditional theories suggested that obesity might increase the mutation rate within cells (due to inflammation or metabolic stress), but genomic data from databases like The Cancer Genome Atlas (TCGA) shows no significant difference in mutational load between obese and non-obese patients.

If the cells aren't mutating faster, why is the cancer risk higher? The authors tackle this paradox by investigating the "Big Organ Hypothesis." They suggest that the risk doesn't come from more mutations per cell, but from having more cells in total. If cancer is a stochastic process—a "bad luck" mutation occurring during cell division—then having a larger organ with more dividing cells simply provides more opportunities for that bad luck to strike.

Methods

The study employed a multi-stage approach to link body mass index (BMI) to organ size and cancer risk:

  1. Literature Extrapolation: The team first searched existing medical literature for data on organ size across different BMI ranges for seven organs: gallbladder, thyroid, liver, pancreas, kidney, gastric cardia, and corpus uteri.
  2. Imaging Analysis (The Core Study): To move beyond literature estimates, they analyzed CT scans from 750 individuals selected from a database of 50,000 at Johns Hopkins Medicine. Expert radiologists manually segmented the 3D volumes of the liver, pancreas, and kidneys.
  3. AI Validation: To ensure robustness, they re-analyzed a subset of 67 scans using a deep learning-based "organ attention network" to automatically calculate volumes, which were then verified by a board-certified radiologist.
  4. Statistical Modeling: They used weighted linear regressions to correlate BMI with organ volume and then compared these volume increases to known relative risks (RR) for cancer in those specific organs.

Datasets

  • Primary Dataset: 750 clinical CT scans from Johns Hopkins Medicine, filtered to exclude patients with known organ diseases or large lesions to ensure "healthy" organ measurements.
  • Validation Subset: 67 scans used for the AI-based segmentation validation.
  • Secondary Data: Relative risk (RR) values for cancer were pulled from established meta-analyses (e.g., IARC reports) to correlate with the measured volume increases.

Key Insights and Ideas

  • The "More Targets" Theory: The most profound insight is that the relationship between organ volume and cancer risk is nearly linear. Mathematically, if you double the number of cells at risk, you approximately double the lifetime risk of cancer. This paper provides the empirical evidence that obesity actually provides that "double."
  • Parenchymal vs. Fat Expansion: A common counter-argument is that obese organs are just "fatty." However, the authors cite research showing that fat content (like in a fatty liver) only accounts for a small fraction of the volume increase. The majority of the growth appears to be an expansion of parenchymal cells—the functional, dividing cells that actually give rise to cancer.
  • The Height Parallel: This mechanism mirrors findings in height-related cancer research. Taller people have higher cancer risks across almost all organs because their organs are larger. This study suggests obesity operates through a similar "biological scaling" law.
  • The BMI-Volume Correlation: The correlation between BMI and organ volume was remarkably strong (median $r = 0.625$), suggesting that BMI is a surprisingly good proxy for internal organ hypertrophy.

Key Results

  • Significant Growth: For every 5-point increase in BMI, the volumes of the kidneys, liver, and pancreas increased by 11%, 13%, and 8%, respectively.
  • Extreme Cases: Individuals with a BMI near 50 (extreme obesity) had organs that were 50% to 100% larger than those with a healthy BMI (20-25).
  • Explaining the Risk: When combining data across the liver, kidneys, and pancreas, the variation in organ volume explained 77% ($R^2 = 0.77$) of the variation in cancer risk attributable to obesity.
  • The Slope of Risk: The linear regression between organ volume ratio and cancer relative risk had a slope of 1.17. This is very close to the theoretical value of 1.0 predicted by mathematical models of tumor evolution (where a 100% increase in cells = 100% increase in risk).

Limitations and Future Work

  • Organ Scope: While the study looked at seven organs via extrapolation, only three (liver, kidneys, pancreas) were directly measured via CT imaging.
  • The Uterine Exception: The model did not fully explain the massive increase in cancer risk for the corpus uteri in obese women, suggesting that in some organs, hormonal factors (like estrogen) play a much larger role than simple cell count.
  • Reversibility: The data is cross-sectional (a snapshot in time). It remains unknown if weight loss through diet or bariatric surgery causes organs to shrink back to "normal" size and whether that subsequently lowers cancer risk.
  • Predictive Power: The authors suggest that in the future, direct measurement of organ volume via imaging might be a more accurate predictor of cancer risk than BMI alone, which is a relatively blunt instrument.

Summary updated

Abstract

Obesity increases significantly cancer risk in various organs. Although this has been recognized for decades, the mechanism through which this happens has never been explained. Here, we show that the volumes of kidneys, pancreas, and liver are strongly correlated (median correlation = 0.625; P-value<10-47) with the body mass index (BMI) of an individual. We also find a significant relationship between the increase in organ volume and the increase in cancer risk (P-value<10-12). These results provide a mechanism explaining why obese individuals have higher cancer risk in several organs: the larger the organ volume the more cells at risk of becoming cancerous. These findings are important for a better understanding of the effects obesity has on cancer risk and, more generally, for the development of better preventive strategies to limit the mortality caused by obesity.
BibTeX
@misc{zhang2020organ,
  author = {Haley Grant Yifan Zhang and Lu Li and Yan Wang and Satomi Kawamoto and Sophie Pénisson and Daniel Fadaei Fouladi and Shahab Shayesteh and Alejandra Blanco and Saeed Ghandili and Eva S. Zinreich and Jefferson S. Graves and Seyoun Park and Scott E. Kern and Jody E. Hooper and Alan Yuille and Elliot K. Fishman and Linda C. Chu and Cristian Tomasetti},
  title = {{Organ size increases with obesity and correlates with cancer risk}},
  year = {2020},
  eprint = {2005.13112},
  archivePrefix = {arXiv},
  url = {https://arxiv.org/abs/2005.13112},
}
Figure